Cargando…

Hybrid immunity versus vaccine-induced immunity against SARS-CoV-2 in patients with autoimmune rheumatic diseases

Detalles Bibliográficos
Autores principales:	Shenoy, Padmanabha, Ahmed, Sakir, Paul, Aby, Cherian, Somy, Umesh, Rashwith, Shenoy, Veena, Vijayan, Anuroopa, Babu, Sageer, S, Nivin, Thambi, Arya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2022
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608390/ https://www.ncbi.nlm.nih.gov/pubmed/34841270 http://dx.doi.org/10.1016/S2665-9913(21)00356-8

Ejemplares similares

Effects of the second dose of COVID-19 vaccines in patients with autoimmune rheumatic diseases with hybrid immunity
por: Menon, Aparna R., et al.
Publicado: (2022)

Effectiveness of delayed second dose of AZD1222 vaccine in patients with autoimmune rheumatic disease
por: Mehta, Pankti, et al.
Publicado: (2022)

Antibody responses after documented COVID-19 disease in patients with autoimmune rheumatic disease
por: Shenoy, Padmanabha, et al.
Publicado: (2021)

Correlates of breakthrough Omicron (B.1.1.529) infections in a prospective cohort of vaccinated patients with rheumatic diseases
por: Benny, Libin, et al.
Publicado: (2023)

Withholding methotrexate after vaccination with ChAdOx1 nCov19 in patients with rheumatoid or psoriatic arthritis in India (MIVAC I and II): results of two, parallel, assessor-masked, randomised controlled trials
por: Skaria, Teny Grace, et al.
Publicado: (2022)

Safety of the ChAdOx1 nCoV-19 and the BBV152 vaccines in 724 patients with rheumatic diseases: a post-vaccination cross-sectional survey
por: Cherian, Somy, et al.
Publicado: (2021)

Withholding methotrexate after COVID-19 vaccination: different strategies, same results? – Author's reply
por: Mehta, Pankti, et al.
Publicado: (2022)

Switching to teleconsultation for rheumatology in the wake of the COVID-19 pandemic: feasibility and patient response in India
por: Shenoy, Padmanabha, et al.
Publicado: (2020)

Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease
por: Gao, Xing-Su, et al.
Publicado: (2022)

Impact of autoimmune risk alleles on the immune system
por: Ray, John P, et al.
Publicado: (2015)

Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseases
por: Felten, Renaud, et al.
Publicado: (2021)

Post-COVID-19 condition in patients with autoimmune rheumatic diseases: the COVID-19 Vaccination in Autoimmune Diseases (COVAD) study
por: Sen, Parikshit, et al.
Publicado: (2023)

SARS-CoV-2: from herd immunity to hybrid immunity
por: Goldblatt, David
Publicado: (2022)

Real-world evidence for prehospital COVID-19 treatment in systemic autoimmune rheumatic disease
por: Bechman, Katie, et al.
Publicado: (2023)

COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases
por: Boekel, Laura, et al.
Publicado: (2022)

Hybrid immunity and strategies for COVID-19 vaccination
por: Hui, David S
Publicado: (2023)

Imprinted hybrid immunity against XBB reinfection
por: Boyton, Rosemary J, et al.
Publicado: (2023)

Dawn of the hybrid immunity era in long-term care facilities
por: Poukka, Eero, et al.
Publicado: (2022)

Considerations of hybrid immunity and the future of adolescent COVID-19 vaccination
por: Irving, Stephanie A, et al.
Publicado: (2023)

Measurement, manipulation and modeling of brain-wide neural population dynamics
por: Shenoy, Krishna V., et al.
Publicado: (2021)

SARS-CoV-2 hybrid immunity: silver bullet or silver lining?
por: Suryawanshi, Rahul, et al.
Publicado: (2022)

Durability of AZD1222 and hybrid humoral immunity against omicron BA.1 and BA.4
por: Soto-Rifo, Ricardo
Publicado: (2023)

Importance of nociplastic pain in patients with rheumatic diseases
por: Alcántara Montero, Antonio
Publicado: (2023)

Immune-Regulatory Mechanisms in Systemic Autoimmune and Rheumatic Diseases
por: Nakken, Britt, et al.
Publicado: (2012)

Immune-Regulatory Mechanisms in Systemic Autoimmune and Rheumatic Diseases
por: Takakubo, Yuya, et al.
Publicado: (2012)

Effect of the COVID-19 pandemic on patients with systemic rheumatic diseases
por: Antonelli, Alessandro, et al.
Publicado: (2021)

COVID-19 in patients with rheumatic disease: finally, a denominator
por: Wallace, Daniel J
Publicado: (2021)

Long COVID in inflammatory rheumatic diseases—what's in a name?
por: Calabrese, Leonard H
Publicado: (2023)

The X in seX-biased immunity and autoimmune rheumatic disease
por: Jiwrajka, Nikhil, et al.
Publicado: (2022)

Immune Axonal Neuropathies Associated With Systemic Autoimmune Rheumatic Diseases
por: Tulbă, Delia, et al.
Publicado: (2021)

Immune thrombocytopenia with multi-organ dysfunction syndrome as a rare presentation of scrub typhus: a case report
por: Ittyachen, Abraham M., et al.
Publicado: (2017)

Arthropathy in Dermatology: A Comprehensive Review
por: Jagadeesan, Soumya, et al.
Publicado: (2017)

Immunity and the coral crisis
por: Palmer, Caroline V.
Publicado: (2018)

Managing patients with rheumatic diseases treated with rituximab during the COVID-19 pandemic
por: Dougados, Maxime
Publicado: (2021)

A prospective longitudinal study evaluating the influence of immunosuppressives and other factors on COVID-19 in autoimmune rheumatic diseases
por: Patil, Abhishek, et al.
Publicado: (2022)

Scaling the immune incline in PDAC
por: Rojas, Luis A., et al.
Publicado: (2021)

Changing COVID-19 outcomes in patients with rheumatic disease—are we really getting better at this?
por: Gianfrancesco, Milena A, et al.
Publicado: (2021)

Activation Markers on B and T Cells and Immune Checkpoints in Autoimmune Rheumatic Diseases
por: Gerasimova, Elena V., et al.
Publicado: (2022)

Connecting the nervous and the immune systems in evolution
por: Hartenstein, Volker, et al.
Publicado: (2018)

Coronavirus is the trigger, but the immune response is deadly
por: Cron, Randy Q
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4ee4ogmb7d31364g1sc3iabjkm